These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist. Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916 [TBL] [Abstract][Full Text] [Related]
6. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist. Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist. Wilson C; Hunt SJ; Tang E; Wright N; Kelly E; Palmer S; Heys C; Mellor S; James R; Bialecki R J Pharmacol Exp Ther; 1999 Sep; 290(3):1085-91. PubMed ID: 10454481 [TBL] [Abstract][Full Text] [Related]
8. Characterization of receptors mediating vascular responses to endothelin-1 in the conscious rat. Filep JG; Clozel M; Fournier A; Földes-Filep E Br J Pharmacol; 1994 Nov; 113(3):845-52. PubMed ID: 7858876 [TBL] [Abstract][Full Text] [Related]
9. Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors. Nambi P; Pullen M; Wu HL; Lee D; Saunders D; Heys R; Aiyar N; Leber J; Elliott J; Brooks D; Ohlstein E; Ruffolo R J Pharmacol Exp Ther; 1996 Jun; 277(3):1567-71. PubMed ID: 8667224 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist. Opgenorth TJ; Adler AL; Calzadilla SV; Chiou WJ; Dayton BD; Dixon DB; Gehrke LJ; Hernandez L; Magnuson SR; Marsh KC; Novosad EI; Von Geldern TW; Wessale JL; Winn M; Wu-Wong JR J Pharmacol Exp Ther; 1996 Feb; 276(2):473-81. PubMed ID: 8632312 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist. Reynolds EE; Keiser JA; Haleen SJ; Walker DM; Olszewski B; Schroeder RL; Taylor DG; Hwang O; Welch KM; Flynn MA J Pharmacol Exp Ther; 1995 Jun; 273(3):1410-7. PubMed ID: 7791115 [TBL] [Abstract][Full Text] [Related]
13. Characterization of peptide and nonpeptide antagonists in human kidney. Kuc RE; Karet FE; Davenport AP J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S373-5. PubMed ID: 8587419 [TBL] [Abstract][Full Text] [Related]
14. Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139. Russell FD; Davenport AP J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S346-7. PubMed ID: 8587410 [TBL] [Abstract][Full Text] [Related]
15. Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype? Hay DW; Luttmann MA; Pullen MA; Nambi P J Pharmacol Exp Ther; 1998 Feb; 284(2):669-77. PubMed ID: 9454813 [TBL] [Abstract][Full Text] [Related]
16. Effects of Ro 47-0203 on endothelin-1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea. Gater PR; Wasserman MA; Renzetti LM Eur J Pharmacol; 1996 May; 304(1-3):123-8. PubMed ID: 8813593 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist. Yuyama H; Sanagi M; Koakutsu A; Mori M; Fujimori A; Harada H; Sudoh K; Miyata K Eur J Pharmacol; 2003 Sep; 478(1):61-71. PubMed ID: 14555186 [TBL] [Abstract][Full Text] [Related]
18. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Shigeno T; Clozel M; Sakai S; Saito A; Goto K Neurosurgery; 1995 Jul; 37(1):87-90; discussion 90-1. PubMed ID: 8587696 [TBL] [Abstract][Full Text] [Related]
19. Identification of a region of the human endothelin ETA receptor required for interaction with bosentan. Adachi M; Furuichi Y; Miyamoto C Eur J Pharmacol; 1994 Oct; 269(2):225-34. PubMed ID: 7851498 [TBL] [Abstract][Full Text] [Related]